The Rxight® test was developed and is performed by MD Labs, a leading CLIA certified laboratory specializing in pharmacogenetic testing.
Rxight® was developed specifically to give patients and caregivers better access to precision medicine. MD Labs has the experience and infrastructure to make pharmacogenetic testing accurate, easy and affordable. By empowering prescribers with DNA drug sensitivity testing insights, MD Labs helps them understand how their patient’s unique genetic profile affects the medications they prescribe.
MD Labs was founded in 2011 with the goal to specialize in prescription monitoring toxicology and to serve prescribers across the United States.
Our founders started the company with the goal of creating a more provider-friendly pharmacogenetic testing service that prides itself on delivering prompt, accurate, reliable and easy to understand results. By employing state of the art pharmacogenomic technology and testing for a wide array of analytes, our team of PhDs and clinical technologists is able to keep ahead of the needs of our community.
Constantly adding services based on client requests and pharmacotherapeutic trends, allows us to provide quick, accurate, and cost-effective pharmacogenetic testing while enhancing prescription adherence and overall patient care. MD Labs began offering pharmacogenetic (PGx) testing as a way for providers to better understand individual patient’s responses to prescription medications and reduce adverse drug reactions.